Maridose Announces Federal License from the U.S. Department of Justice and Drug Enforcement Agency for Bulk Manufacture and Sale of Cannabis and Cannabis-Derived Products

Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Maridose Announces Federal License from the U.S. Department of Justice and Drug Enforcement Agency for Bulk Manufacture and Sale of Cannabis and Cannabis-Derived Products

PR Newswire

BRUNSWICK, Maine, Aug. 19, 2022 /PRNewswire/ -- Maridose LLC announced today that it has received a Federal license from the United States Department of Justice and Drug Enforcement Agency for bulk manufacture of cannabis to supply researchers with any or all of the following Schedule 1 products: marijuana, marijuana extract (including isolated chemical constituents), and tetrahydrocannabinols (THC).

For decades the University of Mississippi had a monopoly on marijuana grown for research. The license granted to Maridose is a step toward ending that monopoly and expanding access to modern cannabis strains for research on cannabis and cannabis-derived products.

Maridose is now an alternative to the University of Mississippi and is licensed by the Drug Enforcement Agency to supply cannabis and its extracts for research use in the United States. "We are very excited to receive this license from the DEA to produce and sell cannabis for research purpose, this a huge step for science and the future of cannabis.", said Richard Shain Maridose's Founder, "Our DEA Registration Number RM063095 is the culmination of over five years of working with the DEA and enables Maridose to legally sell a wide variety of cannabis products through the DEA to researchers and DEA-licensed pharmaceutical companies in the United States and internationally. The DEA has indicated that it will only issue a very limited number of them, and Maridose is proud to be one of the first companies to receive a license. Cannabis businesses operating in states that have state legal cannabis are unable to ship across state lines and operate at legal risk because cannabis remains a Schedule 1 substance at the federal level. Maridose is able to legally supply our customers without these risks and limitations."

About Maridose

Maridose is a leading DEA-licensed biopharmaceutical research and product development company focused on cannabis and cannabis-derived products (DEA Registration Number RM063095). The company was selected by the U.S. Department of Justice and Drug Enforcement Agency to legally cultivate, manufacture and sell cannabis and cannabis-derived products under federal law for research and pharmaceutical applications. Maridose is establishing a center of excellence in Brunswick Landing, Maine for best in class cannabis cultivation, research and product development.

Contact: INVESTORS: Jim Smith [email protected] 650-454-0811
               RESEARCH: Steve Goldner [email protected] 248-515-0097
               CEO/FOUNDER: Richard Shain [email protected] 617-791-1932

Cision View original content:


Copyright CNW Group 2022

Comment On!

Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to (via Easy Blurb).